The Enhancing Oncology Model (EOM) is a voluntary, patient-centered healthcare payment model developed by the Centers for Medicare & Medicaid Services (CMS) to improve cancer care delivery and outcomes while reducing costs. Starting on July 1, 2023, participating physician group practices will trial this model as it seeks to improve performance and financial accountability, with the goal of driving purposeful transformation in oncology care.
At the heart of EOM is a patient-centered approach that considers the unique needs of oncology patients. By providing better support, improving patients’ comprehension of diagnosis and prognosis, and enabling them to adhere to their treatment plan, EOM seeks to enhance patients’ care experience. Key to its success is the redesign of activities and the implementation of patient-focused technology, including electronic patient-reported outcomes (ePROs) and health-focused social screening tools. This technology provides valuable data for better decision-making in treatment, as well as increasing patient and caregiver satisfaction.
How will oncology patients benefit from this patient-centric, clinician and technology-driven EOM?
- EOM puts the patient at the center of a care team that provides equitable, high-value, evidence-based care
- Patients will have 24/7 access to care, patient navigation, and care planning
- EOM increases engagement of patients, oncologists, and other payers in value-based care and quality improvement
 - Improved care quality, health equity, and health outcomes can be observed, while achieving savings over the course of the model test
By leveraging the benefits of EOM, oncology care can be delivered more efficiently and effectively.
The success of EOM will depend in part on the effective integration of technology. Solutions like Clinical ink ePRO provide a simple and intuitive interface for patients who are already overwhelmed from both disease and treatments, while streamlining the data collection process for physicians and oncology practices offers reliability and accuracy to improve overall patient outcomes.
It is clear that patient-centered care is at the forefront of the oncology community, and the EOM is just one example of this shift in focus. For sponsors and CROs, it is critical to adopt a similar patient-centric approach when designing oncology studies. By considering the unique needs of oncology patients and leveraging technologies like Clinical ink eSource, sponsors and CROs can improve patient experience and safety, clinical data quality and integrity, and the efficiency of healthcare providers and study teams.
To learn more about Clinical ink patient-centered solutions that align with the goals of EOM, download our factsheet Eliminate Barriers to Cancer Research with Clinical ink ePRO or speak to an expert to see how we can help.
